Discover
XTNT
Xtant Medical Holdings, Inc.
0.33
5600 x 0.31
300 x 0.47
bid
ask
+
0.01
1.56%
2950 @ 04:00 PM
0.34 +0.01 (3.16%)
| Ytd | -58.21% | |
| 1y | -53.43% |
0.32
day range
0.33
0.31
52 week range
0.92
| Open | 0.33 | Prev Close | 0.32 | Low | 0.32 | High | 0.33 | Mkt Cap | 45.73M |
| Vol | 79.47K | Avg Vol | 1.69M | EPS | -0.08 | P/E | N/A | Forward P/E | -13.43 |
| Beta | 0.39 | Short Ratio | 6.92 | Inst. Own | 65.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 0.36 | 200-d Avg | 0.50 | 1yr Est | 2.25 |
| Income Statement | |||
| Total Revenue | 23.03M | ||
| Revenues (USD) | 23.03M | ||
| Cost of Revenue | 9.70M | ||
| Gross Profit | 13.33M | ||
| Operating Expenses | 22.50M | ||
| Research and Development Expense | 695.00K | ||
| Selling, General and Administrative Expense | 16.80M | ||
| Operating Income | -9.17M | ||
| Interest Expense | 542.00K | ||
| Income Tax Expense | 73.00K | ||
| Net Income | -9.41M | ||
| Net Income Common Stock | -9.41M | ||
| Net Income Common Stock (USD) | -9.41M | ||
| Consolidated Income | -9.41M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -8.80M | ||
| Earning Before Interest & Taxes (USD) | -8.80M | ||
| Weighted Average Shares | 140.26M | ||
| Weighted Average Shares Diluted | 140.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.22M | ||
| Cash and Equivalents (USD) | 10.22M | ||
| Trade and Non-Trade Receivables | 19.42M | ||
| Current Assets | 64.78M | ||
| Property, Plant & Equipment Net | 8.44M | ||
| Total Assets | 79.67M | ||
| Debt Current | 16.33M | ||
| Total Debt | 26.01M | ||
| Current Liabilities | 29.96M | ||
| Debt Non-Current | 9.68M | ||
| Total Liabilities | 39.65M | ||
| Accumulated Retained Earnings (Deficit) | -266.99M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | 40.02M | ||
| Shareholders Equity (USD) | 40.02M | ||
| Assets Non-Current | 14.89M | ||
| Total Debt (USD) | 26.01M | ||
| Goodwill and Intangible Assets | 6.33M | ||
| Inventory | 33.29M | ||
| Liabilities Non-Current | 9.69M | ||
| Trade and Non-Trade Payables | 6.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 508.00K | ||
| Net Cash Flow from Financing | 10.56M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.94M | ||
| Capital Expenditure | -191.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.00M | ||
| Issuance (Repayment) of Debt Securities | 10.60M | ||
| Net Cash Flow from Investing | -5.19M | ||
| Net Cash Flow from Operations | -7.31M | ||
| Effect of Exchange Rate Changes on Cash | 1000 | ||
| Share Based Compensation | 875.00K | ||